Mesoblast (MESO) Long-Term Investments (2017 - 2025)
Mesoblast (MESO) posted quarterly Long-Term Investments of $1.6 million for Q4 2025, up 28.39% year-on-year from $1.2 million in Q4 2024, and up 11.74% on a QoQ basis from $1.4 million in Q2 2025.
Mesoblast (MESO) Long-Term Investments (2017 - 2025) Analysis & Trends
Mesoblast (MESO) has reported Long-Term Investments for 9 consecutive years, with $1.6 million the latest figure, recorded in Q4 2025.
- Quarterly Long-Term Investments rose 28.39% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 28.39% YoY) and the FY2025 annual result came in at $1.4 million, up 36.88% from the prior year.
- Long-Term Investments rose to $1.6 million in Q4 2025 per MESO's latest filing, from $1.4 million in the prior quarter.
- Over the last five years, Long-Term Investments for MESO reached as high as $2.3 million in Q4 2021 and fell as low as $209000.0 in Q2 2021.
- A 5-year average of $1.6 million and a median of $1.8 million in 2022 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2022 — Long-Term Investments soared 741.15% — and 2023, when it tumbled 57.62%.
- Year by year, Long-Term Investments stood at $2.3 million in 2021, then retreated by 16.96% to $1.9 million in 2022, then slumped by 57.62% to $826000.0 in 2023, then soared by 46.25% to $1.2 million in 2024, then increased by 28.39% to $1.6 million in 2025.
- According to Business Quant data, Long-Term Investments over the past three periods registered $1.6 million, $1.4 million, and $1.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | 1.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.55 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Jun 30, 2024 | 1.01 Mn |
| Dec 31, 2023 | 826,000.00 |
| Jun 30, 2023 | 1.76 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 1.95 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 2.03 Mn |
| Dec 31, 2021 | 2.35 Mn |
| Sep 30, 2021 | 2.23 Mn |
| Jun 30, 2021 | 209,000.00 |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 1.90 Mn |
| Sep 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | -446,000.00 |
| Mar 31, 2020 | 1.77 Mn |
| Dec 31, 2019 | 1.67 Mn |